• 3,000 firms
  • Independent
  • Trusted
Save up to 70% on staff

News » Accenture invests in QuantHealth for drug development

Accenture invests in QuantHealth for drug development

Photo from Accenture

NEW YORK and TEL AVIV, ISRAEL — Outsourcing company Accenture has invested $2 million into clinical trial design firm QuantHealth to accelerate its drug development initiatives. 

QuantHealth will funnel the investments into its drug simulation platform, which harnesses artificial intelligence (AI) to treat and analyze its massive 350 million patient data set. 

It boasts 86% accuracy in predicting trial outcomes using the binary endpoint metric. Through QuantHealth’s platform, the drug development chain is swift, has less risk, is cost-efficient, and is better optimized. 

“Clinical trials are a costly and uncertain process, where the R&D cost of a new drug can be upwards of $1 billion,” said Orr Inbar, co-founder and Chief Executive Officer of QuantHealth.

Less than 10% of these medicines make it to the market. Trial failures account for about $50 billion in losses annually — some 20% of the global pharmaceutical research and development budget. The main causes of these failures are lack of drug-population fit and drug-protocol fit.

The investment was made through Accenture Ventures, the firm’s venture capital arm. QuantHealth will be placed under Accenture Venture’s Project Spotlight – an investment program for emerging technology software startups – where it will gain access to Accenture’s team of experts. 

Tom Lounibos, global lead of Accenture Ventures, said: “In addition to accelerating and enhancing global drug discovery efforts, we will work alongside QuantHealth, our clients, and ecosystem partners to expand medicine and treatment options and find new opportunities to bolster patient care.”

Accenture’s investment puts QuantHealth’s Series A funding round at $17 million. In August, the Tel-Aviv-based company received $15 million co-led by Bertelsmann Investments and Pitango HealthTech, with participation from existing investors Shoni Top Ventures and Nina Capital.

Accenture topped the Time Doctor OA500, an index of the world’s top 500 outsourcing firms, with $61.6 billion in annual revenues for fiscal year 2022. The 2024 edition of the OA500 will be released next month. 

Start your
journey today

  • Independent
  • Free
  • Transparent

About OA

Outsource Accelerator is the trusted source of independent information, advisory and expert implementation of Business Process Outsourcing (BPO)

The #1 outsourcing authority

Outsource Accelerator offers the world’s leading aggregator marketplace for outsourcing. It specifically provides the conduit between Philippines outsourcing suppliers and the businesses – clients – across the globe.

The Outsource Accelerator website has over 5,000 articles, 450+ podcast episodes, and a comprehensive directory with 4000+ BPO companies… all designed to make it easier for clients to learn about – and engage with – outsourcing.

About Derek Gallimore

Derek Gallimore has been in business for 20 years, outsourcing for over eight years, and has been living in Manila (the heart of global outsourcing) since 2014. Derek is the founder and CEO of Outsource Accelerator, and is regarded as a leading expert on all things outsourcing.

“Excellent service for outsourcing advice and expertise for my business.”

Learn more
Banner Image
Get 3 Free Quotes Verified Outsourcing Suppliers
3,000 firms.Just 2 minutes to complete.
SAVE UP TO
70% ON STAFF COSTS
Learn more

Connect with over 3,000 outsourcing services providers.

Banner Image

Transform your business with skilled offshore talent.

  • 3,000 firms
  • Simple
  • Transparent
Banner Image